Johnson & Johnson (JNJ) - - Tau txais Johnson & Johnson Report tshaj tawm muaj zog tshaj li qhov xav tau thawj peb lub hlis twg cov nyiaj khwv tau los hnub Tuesday tab sis txo qis nws cov nyiaj tau los tag nrho cov kev kwv yees, thiab ncua nws cov kev taw qhia rau kev muag tshuaj tiv thaiv thaum nws hu ua qhov nyiaj seem thoob ntiaj teb thiab kev thov poob qis.
Johnson & Johnson tau hais tias cov nyiaj tau los hloov kho rau peb lub hlis xaus rau lub Peb Hlis tau pegged ntawm $ 2.67 ib feem, nce 3% los ntawm tib lub sijhawm xyoo tas los thiab 8 xees ua ntej ntawm Txoj Kev pom zoo kwv yees. Cov nyiaj tau los ntawm pab pawg, Johnson & Johnson tau hais tias, tau nce 45% rau $ 23.43 billion, ib daim duab uas nyuam qhuav plam cov kws tshuaj ntsuam qhov kwv yees ntawm $ 23.6 nphom.
Tau qhov twg los: https://www.thestreet.com/markets/johnson-johnson-suspends-vaccine-sales-guide-cuts-profit-forecast?puc=yahoo&cm_ven=YAHOO&yptr=yahoo
